Showing 9971-9980 of 18069 results for "".
- Innovative CT Scan Technique Transforms Prognosis for Head and Neck Cancershttps://reachmd.com/news/innovative-ct-scan-technique-transforms-prognosis-for-head-and-neck-cancers/2471475/Advanced Diagnostic Imaging Enhances Treatment Predictions in Younger Populations A new study highlights how advanced CT imaging techniques can assist oncologists in predicting treatment responses and improving survival rates, particularly for head and neck cancers
- Revolutionizing Orthopedics: The Rise of 3D-Printed Knee Implantshttps://reachmd.com/news/revolutionizing-orthopedics-the-rise-of-3d-printed-knee-implants/2471497/The recent breakthrough in laser 3D printing has paved the way for the creation of total knee implants that are uniquely tailored to fit individual anatomical needs. This technology promises to reduce complications, improve recovery times, and enhance patient outcomes in or
- Exploring the Prognostic Role of Inflammation-Related Genes in Lung Adenocarcinomahttps://reachmd.com/news/exploring-the-prognostic-role-of-inflammation-related-genes-in-lung-adenocarcinoma/2471519/Recent advances in genetic profiling have illuminated the pivotal role of inflammation-related genes in determining the prognosis of lung adenocarcinoma. There is a growing emphasis on integrating precise biomarkers into clinical decision-making
- Revolutionizing Lung Cancer Detection: The Promise of Hybrid Molecular Imaginghttps://reachmd.com/news/revolutionizing-lung-cancer-detection-the-promise-of-hybrid-molecular-imaging/2471520/Overview and Clinical Relevance The novel hybrid molecular imaging test employs targeted antibodies combined with a radioisotope to specifically identify lung cancer cells. This breakthrough method promises to overcome the sensitivity and specificity chall
- ICONIC-LEAD: Icotrokinra Clears Almost Half of Psoriasis Patients in Phase 3 Trialhttps://reachmd.com/news/iconic-lead-icotrokinra-clears-almost-half-of-psoriasis-patients-in-phase-3-trial/2471543/Nearly half of patients with moderate-to-severe plaque psoriasis treated with icotrokinra achieved completely clear skin at week 24, according to new data presented at the 2025 America Academy of Dermatology Annual Meeting. The
- Global Rise in Postmenopausal Osteoarthritis: Unraveling Trends and Impactshttps://reachmd.com/news/global-rise-in-postmenopausal-osteoarthritis-unraveling-trends-and-impacts/2471432/Recent global studies reveal a dramatic over 130% increase in osteoarthritis cases among postmenopausal women, emphasizing the role of hormonal changes in joint degeneration and the resulting rise in associated disabilities. The evolving landsca
- Exploring Hysteroscopic Niche Resection: Anatomical Insights and Symptom Reliefhttps://reachmd.com/news/exploring-hysteroscopic-niche-resection-anatomical-insights-and-symptom-relief/2471422/Hysteroscopic niche resection (HNR) is emerging as a promising treatment for women suffering from postmenstrual spotting. Recent evidence highlights significant anatomical improvements—most notably, an increase in residual myometrial thickness along with a reduction in nich
- Topical Gel Bimiralisib Shows Promise for AK in Interim Resultshttps://reachmd.com/news/Topical-Gel-Bimiralisib-Shows-Promise-AK-Interim-Results/2471537/Interim results from an ongoing Phase 2 clinical trial in actinic keratosis highlighted strong potential for the safety and efficacy of topical gel bimiralisib, a selective pan-PI3K/mTOR inhibitor, Torqur AG announced at the 2025 American Academy of Dermatology (AAD) Annual Meeting in Orlando, Fl
- Exploring the Link Between Iron Dysregulation and Long COVIDhttps://reachmd.com/news/exploring-the-link-between-iron-dysregulation-and-long-covid/2471515/In the wake of the COVID-19 pandemic, emerging research has begun to shed light on a possible mechanism behind long-term complications known as Long COVID. Disruptions in iron regulation following SARS-CoV-2 infection may be a critical factor driving persistent symptoms.
- JAK Inhibitors, Low-Dose Naltrexone Touted as New Options for Nail Lichen Planushttps://reachmd.com/news/JAK-Inhibitors-Low-Dose-Naltrexone-Touted-New-Options-Nail-Lichen-Planus/2471532/JAK inhibitors and low-dose naltrexone appear to be two game-changing options for treatment of nail lichen planus, Shari Lipner, MD, PhD, FAAD, said at the 2025 American Academy of Dermatology (AAD) Annual Meeting in Orlando, Florida. Dr. Lipner noted the activity of the JAK pathway in lic